Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f49d07a09227bc1e4cf5479aa9f1f49 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
filingDate |
1988-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1992-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bff414693f06554c85fa3081828a3075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fd89512ef9cd65da36908844e57f646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad7cb1deebfae20226010b4e1980c3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c06924415479facb6ba1cd5ab59a9fc4 |
publicationDate |
1992-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
SU-1713585-A1 |
titleOfInvention |
Method of lung tuberculosis treatment |
abstract |
This invention relates to medicine, namely phthisiology. The purpose of the invention is to reduce the time of disappearance of intoxication and bacterial excretion during the treatment of pulmonary tuberculosis. For this, in addition to chemotherapeutic agents, the patient was administered 1 time daily for 2 months a-tocopherol intramuscularly at a dose of 0.1 g in combination with ascorbic acid orally at a dose of 1.0 g and sodium nucleinate at an oral dose of 0.9 1 tab. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111686171-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005107740-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005107741-A1 |
priorityDate |
1988-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |